Skip to main content

What to Expect From Ingersoll Rand's Next Quarterly Earnings Report

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Valued at a market cap of $34 billion, Ingersoll Rand Inc. (IR) provides various mission-critical air, fluid, energy, and medical technologies services and solutions. The Davidson, North Carolina-based company is ready to announce its fiscal Q4 earnings for 2025 after the market closes on Thursday, Feb. 12. 

Before this event, analysts expect this industrial company to report a profit of $0.88 per share, up 8.6% from $0.81 per share in the year-ago quarter. The company has met Wall Street’s bottom-line estimates in three of the last four quarters, while missing on another occasion. Its earnings of $0.83 per share in the previous quarter came in line with the consensus estimates. 

 

For the current fiscal year, ending in December, analysts expect IR to report a profit of $3.17 per share, down marginally from $3.18 per share in fiscal 2024. Nonetheless, its EPS is expected to grow 6.6% year-over-year to $3.38 in fiscal 2026.

www.barchart.com 

IR has declined 3.6% over the past 52 weeks, considerably lagging behind both the S&P 500 Index's ($SPX16.7% return and the State Street Industrial Select Sector SPDR ETF’s (XLI22.5% uptick over the same time period. 

www.barchart.com 

On Jan. 5, IR shares rose 3.1% following the acquisition of Scinomix, Inc., which strengthened the company’s life sciences portfolio. The deal is expected to enhance IR’s ability to offer more end-to-end solutions by leveraging technologies that improve workflow efficiency through higher levels of automation and accuracy for customers.

Wall Street analysts are moderately optimistic about IR’s stock, with a "Moderate Buy" rating overall. Among 16 analysts covering the stock, eight recommend "Strong Buy," and eight suggest "Hold.” The mean price target for IR is $89.64, indicating a 2.7% potential upside from the current levels.


On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  265.06
+2.02 (0.77%)
AAPL  271.35
+1.18 (0.44%)
AMD  354.49
+17.38 (5.16%)
BAC  53.46
+0.58 (1.10%)
GOOG  381.94
+34.63 (9.97%)
META  611.91
-57.21 (-8.55%)
MSFT  407.78
-16.68 (-3.93%)
NVDA  199.57
-9.68 (-4.63%)
ORCL  161.39
-2.44 (-1.49%)
TSLA  381.63
+8.83 (2.37%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.